Linnik MD - Search Results

1

Abetimus sodium for renal flare in systemic lupus erythematosus: results of a randomized, controlled phase III trial.

Cardiel MH, Tumlin JA, Furie RA, Wallace DJ, Joh T, Linnik MD; LJP 394-90-09 Investigator Consortium. Cardiel MH, et al. Among authors: linnik md. Arthritis Rheum. 2008 Aug;58(8):2470-80. doi: 10.1002/art.23673. Arthritis Rheum. 2008. PMID: 18668592 Free article. Clinical Trial.

2

Gene expression induced by cerebral ischemia: an apoptotic perspective.

MacManus JP, Linnik MD. MacManus JP, et al. Among authors: linnik md. J Cereb Blood Flow Metab. 1997 Aug;17(8):815-32. doi: 10.1038/aj.jcbfm.9590266. J Cereb Blood Flow Metab. 1997. PMID: 9290580 Review. No abstract available.

3

Identification of immunoreactive substance P in human and other mammalian endothelial cells.

Linnik MD, Moskowitz MA. Linnik MD, et al. Peptides. 1989 Sep-Oct;10(5):957-62. doi: 10.1016/0196-9781(89)90175-7. Peptides. 1989. PMID: 2481848

4

Pre-treatment affinity for LJP 394 influences pharmacodynamic response in lupus patients.

McNeeley PA, Iverson GM, Furie RA, Cash JM, Cronin ME, Katz RS, Weisman MH, Aranow C, Linnik MD. McNeeley PA, et al. Among authors: linnik md. Lupus. 2001;10(8):526-32. doi: 10.1191/096120301701549642. Lupus. 2001. PMID: 11530993 Clinical Trial.

5

LJP 394 for the prevention of renal flare in patients with systemic lupus erythematosus: results from a randomized, double-blind, placebo-controlled study.

Alarcón-Segovia D, Tumlin JA, Furie RA, McKay JD, Cardiel MH, Strand V, Bagin RG, Linnik MD, Hepburn B; LJP 394 Investigator Consortium. Alarcón-Segovia D, et al. Among authors: linnik md. Arthritis Rheum. 2003 Feb;48(2):442-54. doi: 10.1002/art.10763. Arthritis Rheum. 2003. PMID: 12571854 Free article. Clinical Trial.

6

Relationship between anti-double-stranded DNA antibodies and exacerbation of renal disease in patients with systemic lupus erythematosus.

Linnik MD, Hu JZ, Heilbrunn KR, Strand V, Hurley FL, Joh T; LJP 394 Investigator Consortium. Linnik MD, et al. Arthritis Rheum. 2005 Apr;52(4):1129-37. doi: 10.1002/art.20980. Arthritis Rheum. 2005. PMID: 15818711 Free article. Clinical Trial.

7

Clinical trial parameters that influence outcomes in lupus trials that use the systemic lupus erythematosus responder index.

Kalunian KC, Urowitz MB, Isenberg D, Merrill JT, Petri M, Furie RA, Morgan-Cox MA, Taha R, Watts S, Silk M, Linnik MD. Kalunian KC, et al. Among authors: linnik md. Rheumatology (Oxford). 2018 Jan 1;57(1):125-133. doi: 10.1093/rheumatology/kex368. Rheumatology (Oxford). 2018. PMID: 29045736 Free article.

8

Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial.

Wallace DJ, Furie RA, Tanaka Y, Kalunian KC, Mosca M, Petri MA, Dörner T, Cardiel MH, Bruce IN, Gomez E, Carmack T, DeLozier AM, Janes JM, Linnik MD, de Bono S, Silk ME, Hoffman RW. Wallace DJ, et al. Among authors: linnik md. Lancet. 2018 Jul 21;392(10143):222-231. doi: 10.1016/S0140-6736(18)31363-1. Lancet. 2018. PMID: 30043749 Clinical Trial.

9

Beta2-glycoprotein I-dependent anticardiolipin antibodies preferentially bind the amino terminal domain of beta2-glycoprotein I.

McNeeley PA, Dlott JS, Furie RA, Jack RM, Ortel TL, Triplett DA, Victoria EJ, Linnik MD. McNeeley PA, et al. Among authors: linnik md. Thromb Haemost. 2001 Aug;86(2):590-5. Thromb Haemost. 2001. PMID: 11522008

10

Pharmacokinetics of high-dose abetimus sodium in normal subjects with specific assessment of effect on coagulation.

Linnik MD, O'Rourke AM, Crowther MA. Linnik MD, et al. J Clin Pharmacol. 2008 Aug;48(8):909-18. doi: 10.1177/0091270008319465. Epub 2008 May 29. J Clin Pharmacol. 2008. PMID: 18511650 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

58 results

Search Page